Figure 2.1. Stages of Development of Colorectal Cancer

Figure 2.2. The Principle of Positron Emission Detectable by Tomography

Table 1.1. Incidence, Number of Deaths, and Relative 5-Year Survival Rates by Stage of Diagnosis for Selected Cancers (United States)

Table 1.2. American Cancer Society Recommendations for the Early Detection of Cancer in Average-Risk Asymptomatic People (2005)

Table 2.1. Multicenter Clinical Trials Comparing Computed Tomography Colonography with Colonoscopy

Table 2.2. Comparison of Computed Tomographic Colonography and Colonoscopy as Screening Tests for Colorectal Cancer and Polyps

Table 2.3. Summary of Breast Cancer Screening Techniques

Table 2.4. Selected Companies Marketing Imaging Systems for Detection and Diagnosis of Breast Cancer

Table 2.5. Positron Emission Tomography Cancer Imaging Applications Covered by Medicare

Table 2.6. Companies Developing/Marketing In Vivo Diagnostic, Monoclonal Antibody–Based Imaging Agents

Table 3.1. Selected In Vitro Diagnostic Assays Available or in Development for Colorectal Cancer Screening

Table 3.2. Selected Anti–Epidermal Growth Factor Receptor Monoclonal Antibodies on the Market or in Development

Table 3.3. Selected Available Epidermal Growth Factor Receptor Tests/Reagents

Table 3.4. Selected Targeted Therapies on the Market for Treatment of Leukemia or Lymphoma

Table 3.5. Selected In Vitro Molecular Diagnostic Tests Available or in Development for Leukemia and Lymphoma

Table 3.6. Selected Examples of Diagnostic Company Activities to Search for Novel Cancer Biomarkers and Develop New Cancer Diagnostic Tests